Akebia Therapeutics Inc
SWB:AX9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akebia Therapeutics Inc
SWB:AX9
|
US |
|
V
|
Vidrala SA
SWB:VIR
|
ES |
|
C
|
Consolidated Edison Inc
XBER:EDC
|
US |
|
Proto Labs Inc
LSE:0KRR
|
US |
|
S
|
Synchrony Financial
XETRA:SFE
|
US |
|
L
|
LHC Group Inc
F:LH6
|
US |
|
C
|
Construction Partners Inc
F:CQY
|
US |
|
S
|
Swisscom AG
SWB:SWJA
|
CH |
|
Posco Holdings Inc
NYSE:PKX
|
KR |
|
I
|
Intel Corp
XMUN:INL
|
US |
|
A
|
America Movil SAB de CV
F:MV9
|
MX |
|
Emerita Resources Corp
XTSX:EMO
|
CA |
|
Orell Fuessli AG
F:OFH
|
CH |
|
Z
|
Zurich Insurance Group AG
XMUN:ZFIN
|
CH |
|
B
|
Boeing Co
F:BCO
|
US |
|
Regional Management Corp
NYSE:RM
|
US |
|
BJ's Wholesale Club Holdings Inc
NYSE:BJ
|
US |
|
Z
|
Z Holdings Corp
XBER:YOJ
|
JP |
|
R
|
RWE AG
F:RWEA
|
DE |
|
Computacenter PLC
LSE:CCC
|
UK |
|
T
|
TUI AG
SWB:TUI1
|
DE |
|
E
|
Elis SA
OTC:ELSSF
|
FR |
|
H
|
Honeywell International Inc
F:ALD
|
US |
|
Credit Agricole SA
MIL:ACA
|
FR |
Wall St Price Targets
AX9 Price Targets Summary
Akebia Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AX9 is 3.66 EUR with a low forecast of 2.47 EUR and a high forecast of 5.13 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AX9's stock price target?
Price Target
3.66
EUR
According to Wall Street analysts, the average 1-year price target for AX9 is 3.66 EUR with a low forecast of 2.47 EUR and a high forecast of 5.13 EUR.
What is the Revenue forecast for Akebia Therapeutics Inc?
Projected CAGR
12%
The compound annual growth rate for Revenue over the next 8 years is 12%.
What is the Operating Income forecast for Akebia Therapeutics Inc?
Projected CAGR
39%
The compound annual growth rate for Operating Income over the next 8 years is 39%.
